A First-in-Human Study of CKD-703 in Advanced Solid Tumors and Non-Small Cell Lung Cancer
Clinical trial NCT07439094 · RECRUITING
Trial details
- NCT number
- NCT07439094
- Sponsor
- Chong Kun Dang Pharmaceutical
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-16
- Primary completion
- 2029-12-01
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.